(ii) Specific instances
Without limiting paragraph (c)(i), the directors of Arana confirm in the Target's Statement that, as a result (directly or indirectly) of the acquisition or proposed acquisition of Arana Shares by Cephalon International, none of Centocor Inc., Abbott Laboratories Inc., Domantis Limited and any of their respective affiliates becomes entitled to exercise any right under any provision of an agreement with any member of the Arana Group, which right, upon its exercise, results or would result, or could reasonably be expected to result, in any such agreement or other instrument being terminated or varied or any other action being taken or arising under it.
(d) No prescribed occurrences
(i) Between the time beginning when the Bidder's Statement is given to Arana and ending at the end of the Offer Period, none of the following occurrences happens:
(A) Arana converts all or any of the Arana Shares into a larger or smaller number of Arana Shares;
(B) any member of the Arana Group resolves to reduce its share capital in any way;
(C) any member of the Arana Group enters into a buy-back agreement or resolves to approve the terms of a buy-back agreement under section 257C(1) or 257D(1) of the Corporations Act;
(D) any member of the Arana Group issues shares (other than pursuant to Performance Rights) or grants an option over its shares, or agrees to make such an issue or grant such an option;
(E) any member of the Arana Group issues, or agrees to issue, convertible notes;
(F) any member of the Arana Group disposes, or agrees to dispose, of the whole, or a substantial part, o
|SOURCE Cephalon, Inc.|
Copyright©2009 PR Newswire.
All rights reserved